Human Medicines European Public Assessment Report (EPAR): Mysimba, Naltrexone / Bupropion, Obesity,Overweight, Date of Authorisation: 26/03/2015, Revision: 11, Status: Authorised

Case Medical Research
doi 10.31525/cmr-11ef04b
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy